Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase

Appl Biochem Biotechnol. 2016 Aug;179(7):1202-12. doi: 10.1007/s12010-016-2059-y. Epub 2016 Mar 29.

Abstract

This study aimed to investigate fragments derived from human and bovine lactoferrins for ability to inhibit nuclear translocation of HIV-1 integrase. It was shown that human lactoferricin, human lactoferrin 1-11, and bovine lactoferrampin reduced nuclear distribution of HIV-1 integrase. Bovine lactoferrampin could inhibit both the activity and nuclear translocation of HIV-1 integrase. Human lactoferrampin, bovine lactoferricin, and bovine lactoferrin 1-11 had no effect on HIV-1 integrase nuclear translocation. Human lactoferrampin which inhibited the activity of integrase did not prevent its nuclear translocation. Human lactoferricin and lactoferrin 1-11 did not inhibit HIV-1 integrase nuclear translocation despite their ability to attenuate the enzyme activity. The discrepancy between the findings on reduction of HIV-1 activity and inhibition of nuclear translocation of HIV-1 integrase was due to the different mechanisms involved. A similar reasoning can also be applied to the different inhibitory potencies of the milk peptides on different HIV enzymes, i.e., nuclear translocation.

Keywords: HIV-1 integrase; Milk peptides; Nuclear translocation.

MeSH terms

  • Animals
  • Cattle
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • HIV Integrase / genetics
  • HIV Integrase / metabolism*
  • HIV Integrase Inhibitors / pharmacology
  • HIV-1 / drug effects*
  • HIV-1 / pathogenicity
  • Humans
  • Lactoferrin / genetics*
  • Lactoferrin / pharmacology
  • Peptide Fragments / genetics*
  • Peptide Fragments / pharmacology
  • Protein Transport / drug effects

Substances

  • HIV Integrase Inhibitors
  • Peptide Fragments
  • lactoferrampin
  • lactoferrin (1-11), human
  • lactoferricin B
  • HIV Integrase
  • Lactoferrin